155 related articles for article (PubMed ID: 37464833)
1. Objective Value of the Apparent Diffusion Coefficient (ADC) Map from Ultrahigh b-value Diffusion-weighted Imaging (DWI) in 3T MRI could be a Non-invasive Specific Biomarker for Prostate Cancer.
Zhang K; Zhang C; Chen Z; Zhang Y; Dong Z; Hu Y; Wang M; Fu Y; Ye H; Shen Y
Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37464833
[TBL] [Abstract][Full Text] [Related]
2. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
[TBL] [Abstract][Full Text] [Related]
3. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
4. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
5. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
[TBL] [Abstract][Full Text] [Related]
7. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
9. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
11. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.
Kocakoc E; Bakan AA; Poyrazoglu OK; Dagli AF; Gul Y; Cicekci M; Bahcecioglu IH
Med Princ Pract; 2015; 24(6):522-6. PubMed ID: 26183515
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
15. Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Histogram Analysis of Apparent Diffusion Coefficient Maps With Standard and Ultrahigh b-value Diffusion-weighted MR Imaging.
Lu ZH; Ji LB; Zhao WL; Zhang YS; Wu JF; Li X; Shen JK
J Comput Assist Tomogr; 2019; 43(2):235-241. PubMed ID: 30475249
[TBL] [Abstract][Full Text] [Related]
16. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
[TBL] [Abstract][Full Text] [Related]
17. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.
Mussi TC; Martins T; Tachibana A; Mousessian PN; Baroni RH
Int Braz J Urol; 2018; 44(5):882-891. PubMed ID: 30044597
[TBL] [Abstract][Full Text] [Related]
18. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
Park SY; Kim CK; Park BK; Kwon GY
AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
20. [Application study of qualitatively diagnosing prostate cancer using ultrahigh b-value DWI].
Ji LB; Lu ZH; Yao HH; Cao Y; Lu WW; Qian WX; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(27):2107-2110. PubMed ID: 28763884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
